Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India
Background: Mucormycosis is an uncommon fungal infection with high morbidity and mortality. There had been a sudden surge in the cases of mucormycosis during the second wave of Coronavirus Disease 2019 (COVID-19) in India. Objective: The etiology, pathophysiology, and correlations of mucormycosis at...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bucharest College of Physicians
2021-12-01
|
| Series: | Modern Medicine |
| Subjects: | |
| Online Access: | https://medicinamoderna.ro/wp-content/uploads/2021/12/Mucormycosis-Infections-during-the-Second-Wave-of-COVID-19-Experience-from-a-Tertiary-Care-Centre-in-India-10.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850145141770158080 |
|---|---|
| author | Sudhir BHANDARI Shivankan KAKKAR Amitabh DUBE Mohnish GROVER Shruti BHARGAVA Amit TAK Bhoopendra PATEL Minal KACHHAWA |
| author_facet | Sudhir BHANDARI Shivankan KAKKAR Amitabh DUBE Mohnish GROVER Shruti BHARGAVA Amit TAK Bhoopendra PATEL Minal KACHHAWA |
| author_sort | Sudhir BHANDARI |
| collection | DOAJ |
| description | Background: Mucormycosis is an uncommon fungal infection with high morbidity and mortality. There had been a sudden surge in the cases of mucormycosis during the second wave of Coronavirus Disease 2019 (COVID-19) in India. Objective: The etiology, pathophysiology, and correlations of mucormycosis at tertiary hospital in India is explored in the present study. Methods: In this retrospective observational study, all coronavirus disease associated mucormycosis (CAM) cases admitted at this center between April 2021 to June 2021 were included. The cases were evaluated in terms of their background, most common presentations, chief underlying etiologies, severity of disease, comorbidities, investigation profiles, prognosis, and treatment provided. Results: Among the total 231 cases reported with mucormycosis, age group of 40 - 50 years (28%) was the most afflicted and the 20 30 year was the least. Men (68%) were more afflicted than Women. 66% patients had a history of vaccination against COVID-19. 63% patients presented with a High-Resolution Computerized Tomography (HRCT) score of 9-16. 60% required oxygen support and 71% required steroids. Diabetes mellitus was the most prevalent comorbidity. Conclusion: The salience of the second inferno wave of COVID-19 was witness to COVID-19 patients who had pre existing diabetes mellitus. Individuals with diabetes in general foster more extreme COVID-19 infections and end up using corticosteroids. In any case, the corticosteroids – alongside diabetes – increment the danger of getting mucormycosis. The specific pathophysiology of COVID-19 may represent co-morbidity with Invasive Fungal diseases (IFI). |
| format | Article |
| id | doaj-art-c873e4aacb0248539bbb1021666ca2d5 |
| institution | OA Journals |
| issn | 1223-0472 2360-2473 |
| language | English |
| publishDate | 2021-12-01 |
| publisher | Bucharest College of Physicians |
| record_format | Article |
| series | Modern Medicine |
| spelling | doaj-art-c873e4aacb0248539bbb1021666ca2d52025-08-20T02:28:09ZengBucharest College of PhysiciansModern Medicine1223-04722360-24732021-12-01284425431https://doi.org/10.31689/rmm.2021.28.4.425Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in IndiaSudhir BHANDARI0Shivankan KAKKAR1Amitabh DUBE2Mohnish GROVER3Shruti BHARGAVA4Amit TAK5Bhoopendra PATEL6Minal KACHHAWA7Department of Medicine, S. M. S. Medical College & Attached Hospital, Jaipur, Rajasthan, IndiaDepartment of Pharmacology, S. M. S. Medical College & Attached Hospital, Jaipur, Rajasthan, IndiaDepartment of Physiology, S. M. S. Medical College & Attached Hospital, Jaipur, Rajasthan, IndiaDepartment of ENT, S. M. S. Medical College & Attached Hospital, Jaipur, Rajasthan, IndiaDepartment of Pathology, S. M. S. Medical College & Attached Hospital, Jaipur, Rajasthan, IndiaRajmata Vijaya Raje Scindia Medical College, Bhilwara, Rajasthan, IndiaDepartment of Physiology, All India InstituDepartment of Physiology, All India Institute of Medical Sciences (AIIMS), Bilaspur, Himachal Pradesh, Indiate of Medical Sciences (AIIMS), Bilaspur, Himachal Pradesh, IndiaDepartment of Physiology, S. M. S. Medical College & Attached Hospital, Jaipur, Rajasthan, IndiaBackground: Mucormycosis is an uncommon fungal infection with high morbidity and mortality. There had been a sudden surge in the cases of mucormycosis during the second wave of Coronavirus Disease 2019 (COVID-19) in India. Objective: The etiology, pathophysiology, and correlations of mucormycosis at tertiary hospital in India is explored in the present study. Methods: In this retrospective observational study, all coronavirus disease associated mucormycosis (CAM) cases admitted at this center between April 2021 to June 2021 were included. The cases were evaluated in terms of their background, most common presentations, chief underlying etiologies, severity of disease, comorbidities, investigation profiles, prognosis, and treatment provided. Results: Among the total 231 cases reported with mucormycosis, age group of 40 - 50 years (28%) was the most afflicted and the 20 30 year was the least. Men (68%) were more afflicted than Women. 66% patients had a history of vaccination against COVID-19. 63% patients presented with a High-Resolution Computerized Tomography (HRCT) score of 9-16. 60% required oxygen support and 71% required steroids. Diabetes mellitus was the most prevalent comorbidity. Conclusion: The salience of the second inferno wave of COVID-19 was witness to COVID-19 patients who had pre existing diabetes mellitus. Individuals with diabetes in general foster more extreme COVID-19 infections and end up using corticosteroids. In any case, the corticosteroids – alongside diabetes – increment the danger of getting mucormycosis. The specific pathophysiology of COVID-19 may represent co-morbidity with Invasive Fungal diseases (IFI).https://medicinamoderna.ro/wp-content/uploads/2021/12/Mucormycosis-Infections-during-the-Second-Wave-of-COVID-19-Experience-from-a-Tertiary-Care-Centre-in-India-10.pdfcovid-19coronavirus disease associated mucormycosis (cam)corticosteroidsdiabetes mellitus |
| spellingShingle | Sudhir BHANDARI Shivankan KAKKAR Amitabh DUBE Mohnish GROVER Shruti BHARGAVA Amit TAK Bhoopendra PATEL Minal KACHHAWA Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India Modern Medicine covid-19 coronavirus disease associated mucormycosis (cam) corticosteroids diabetes mellitus |
| title | Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India |
| title_full | Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India |
| title_fullStr | Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India |
| title_full_unstemmed | Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India |
| title_short | Mucormycosis Infections during the Second Wave of COVID-19: Experience from a Tertiary Care Centre in India |
| title_sort | mucormycosis infections during the second wave of covid 19 experience from a tertiary care centre in india |
| topic | covid-19 coronavirus disease associated mucormycosis (cam) corticosteroids diabetes mellitus |
| url | https://medicinamoderna.ro/wp-content/uploads/2021/12/Mucormycosis-Infections-during-the-Second-Wave-of-COVID-19-Experience-from-a-Tertiary-Care-Centre-in-India-10.pdf |
| work_keys_str_mv | AT sudhirbhandari mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT shivankankakkar mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT amitabhdube mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT mohnishgrover mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT shrutibhargava mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT amittak mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT bhoopendrapatel mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia AT minalkachhawa mucormycosisinfectionsduringthesecondwaveofcovid19experiencefromatertiarycarecentreinindia |